What is Tirzepatide?
Research use only. The summary below reflects reports in research literature. It is not medical advice or instructions for human use. Tirzepatide is sold strictly for research and analytical purposes.
Ordering from the EU? See Tirzepatide on our EU store on our European store, with EU delivery.
In Deutschland? See Tirzepatide on our EU store on Body Pharm Deutschland, with German delivery.
In Czechia? See Tirzepatide on our EU store on Body Pharm Česko, with delivery within Czechia.
In Spain? See Tirzepatide on our EU store on Body Pharm España, with delivery within Spain.
What is Tirzepatide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide, supplied for research as a pre-filled multi-dose pen.
It is one of the most-studied incretin peptides in weight-loss and metabolic research, adding a GIP arm to the GLP-1 mechanism. Research outcomes vary with dose and duration.
Reported side effects
- Nausea and appetite suppression — the most frequently reported effects, typically dose-dependent.
- Other gastrointestinal effects (fullness, altered bowel habit) at higher doses.
- Mild, transient injection-site reactions.
How to dose Tirzepatide
Dosed once weekly on a stepwise ramp — a common research schedule is 2.5 → 5 → 7.5 → 10 → up to 15 mg, increasing every four weeks. The pen sets each step precisely.
Read the full Tirzepatide dosing protocolHow to get Tirzepatide
The Body Pharm Tirzepatide pen is a sealed, HPLC-tested device with a published Certificate of Analysis. It is currently on the waitlist — reserve it and we notify you the moment it's released. Sold for research use only.
Cost per month
Confirmed on release — reserve free on the waitlist, no payment taken.
Published HPLC COA · free discreet UK delivery
All Body Pharm products are sold strictly for research and analytical purposes only. Not for human consumption.